| Market Cap | 773.51M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -21.19M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -20.00% |
| Sales | 50.88M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -8.00% |
| Dividend | N/A | Price/Book | 5.00 | EPS next 5Y | - | 52W High Chg | -43.00% |
| Recommedations | - | Quick Ratio | 3.79 | Shares Outstanding | 492.63M | 52W Low Chg | 53.00% |
| Insider Own | 14.98% | ROA | -13.14% | Shares Float | 399.36M | Beta | 0.54 |
| Inst Own | 8.29% | ROE | -35.33% | Shares Shorted/Prior | -/- | Price | 0.75 |
| Gross Margin | 70.22% | Profit Margin | -41.66% | Avg. Volume | 3,649 | Target Price | - |
| Oper. Margin | -34.38% | Earnings Date | - | Volume | 400 | Change | 0.00% |
Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel. As of December 16, 2021, Itamar Medical Ltd. operates as a subsidiary of ZOLL Medical Corporation.